Peers of NeOnc Technologies Holdings Inc (NTHI)
Health Care · Pharmaceuticals
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
-3.29x
As of Jun 29, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Jun 29, 2026 | -3.29x |
| Jun 26, 2026 | -3.40x |
| Jun 25, 2026 | -3.35x |
| Jun 24, 2026 | -3.50x |
| Jun 23, 2026 | -3.62x |
| Jun 22, 2026 | -3.80x |
| Jun 18, 2026 | -3.91x |
| Jun 17, 2026 | -3.57x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
